All Stories

  1. Vincristine treatment reverses podocyte damage in focal segmental glomerulosclerosis
  2. Reversal of elevatedGli3in Autosomal Recessive Polycystic Kidney Disease does not alter cystogenesis
  3. Cell Catcher: A New Method to Extract and Preserve Live Renal Cells from Urine
  4. Single‐cell transcriptomics identifies aberrant glomerular angiogenic signalling in the early stages of WT1 kidney disease
  5. SGLT1 contributes to glucose-mediated exacerbation of ischemia–reperfusion injury in ex vivo rat heart
  6. Cardiotrophin‐1 therapy reduces disease severity in a murine model of glomerular disease
  7. A unique subset of pericystic endothelium associates with aberrant microvascular remodelling and impaired blood perfusion early in polycystic kidney disease
  8. A microfluidic platform integrating functional vascularized organoids-on-chip
  9. Cell Catcher: a new method to extract and preserve live renal cells from urine
  10. Mapping the blood vasculature in an intact human kidney using hierarchical phase-contrast tomography
  11. Hyperglycemic exacerbation of myocardial infarction through SGLT1 - a glucose paradox
  12. Three-dimensional imaging and single-cell transcriptomics of the human kidney implicate perturbation of lymphatics in alloimmunity
  13. Systemic gene therapy with thymosin β4 alleviates glomerular injury in mice
  14. The timing of auditory sensory deficits in Norrie disease has implications for therapeutic intervention
  15. ­­­Kidney organoids recapitulate human basement membrane assembly in health and disease
  16. Imaging intact human organs with local resolution of cellular structures using hierarchical phase-contrast tomography
  17. Experimental long-term diabetes mellitus alters the transcriptome and biomechanical properties of the rat urinary bladder
  18. Identification of an Altered Matrix Signature in Kidney Aging and Disease
  19. Systemic gene therapy with thymosin β4 alleviates glomerular injury in mice
  20. Mechanisms and cell lineages in lymphatic vascular development
  21. The Biological Significance and Implications of Planar Cell Polarity for Nephrology
  22. Multiscale three-dimensional imaging of intact human organs down to the cellular scale using hierarchical phase-contrast tomography
  23. Antenatal biological models in the characterization and research of congenital lower urinary tract disorders
  24. Endothelial-epithelial communication in polycystic kidney disease: Role of vascular endothelial growth factor signalling
  25. Pseudouridylation defect due to DKC1 and NOP10 mutations causes nephrotic syndrome with cataracts, hearing impairment, and enterocolitis
  26. Beyond a Passive Conduit: Implications of Lymphatic Biology for Kidney Diseases
  27. Free 25-hydroxyvitamin-D concentrations are lower in children with renal transplant compared with chronic kidney disease
  28. Spatiotemporal dynamics and heterogeneity of renal lymphatics in mammalian development and cystic kidney disease
  29. Generating Mutant Renal Cell Lines Using CRISPR Technologies
  30. Tissue Clearing and Deep Imaging of the Kidney Using Confocal and Two-Photon Microscopy
  31. Overexpression of Circulating Soluble Nogo-B Improves Diabetic Kidney Disease by Protecting the Vasculature
  32. Arterial “inflammaging” drives vascular calcification in children on dialysis
  33. SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart
  34. Planar cell polarity in organ formation
  35. Vangl2, a planar cell polarity molecule, is implicated in irreversible and reversible kidney glomerular injury
  36. In vivo three-dimensional photoacoustic imaging of the renal vasculature in preclinical rodent models
  37. Thymosin-β4: A key modifier of renal disease
  38. Lithium induces mesenchymal-epithelial differentiation during human kidney development by activation of the Wnt signalling system
  39. HeterozygousVangl2Looptailmice reveal novel roles for the planar cell polarity pathway in adult lung homeostasis and repair
  40. Planar cell polarity genes Celsr1 and Vangl2 are necessary for kidney growth, differentiation, and rostrocaudal patterning
  41. Vascular growth factors play critical roles in kidney glomeruli
  42. The role of thymosin-β4 in kidney disease
  43. Vascular Endothelial Growth Factor C for Polycystic Kidney Diseases
  44. HDL in Children with CKD Promotes Endothelial Dysfunction and an Abnormal Vascular Phenotype
  45. Planar cell polarity and the kidney
  46. Targeted Glomerular Angiopoietin-1 Therapy for Early Diabetic Kidney Disease
  47. Albuminuria is associated with too few glomeruli and too much testosterone
  48. Circulating Angiopoietin-2 Is a Marker for Early Cardiovascular Disease in Children on Chronic Dialysis
  49. Mechanistic Insights into Vascular Calcification in CKD
  50. Angiogenesis and autosomal dominant polycystic kidney disease
  51. The renal archaeologist: digging for clues in archived tissues to understand diabetic kidney disease
  52. Restoring the renal microvasculature to treat chronic kidney disease
  53. An unusual case of pediatric shortness of breath—questions
  54. Selective Stimulation of VEGFR2 Accelerates Progressive Renal Disease
  55. Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney Injury
  56. The planar cell polarity gene Vangl2 is required for mammalian kidney-branching morphogenesis and glomerular maturation
  57. Mutations in HPSE2 Cause Urofacial Syndrome
  58. Corticosteroid-induced kidney dysmorphogenesis is associated with deregulated expression of known cystogenic molecules, as well as indian hedgehog
  59. Sphingosine kinase-1: a potential mediator of renal fibrosis
  60. Abnormal Angiogenesis in Diabetic Nephropathy
  61. Unraveling the Genetic Landscape of Bladder Development in Mice
  62. HNF1BMutations Associate with Hypomagnesemia and Renal Magnesium Wasting
  63. Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism
  64. Roles of Angiopoietins in Kidney Development and Disease: Figure 1.
  65. Teashirt 3 is necessary for ureteral smooth muscle differentiation downstream of SHH and BMP4
  66. Angiopoietin-1 therapy enhances fibrosis and inflammation following folic acid-induced acute renal injury
  67. Podocyte-Specific Expression of Angiopoietin-2 Causes Proteinuria and Apoptosis of Glomerular Endothelia
  68. Microarray interrogation of human metanephric mesenchymal cells highlights potentially important molecules in vivo
  69. Vascular endothelial growth factor administration does not improve microvascular disease in the salt-dependent phase of post-angiotensin II hypertension
  70. Experimental short-term fetal bladder outflow obstruction: I. Morphology and cell biology associated with urinary flow impairment
  71. Vascular endothelial growth factor stimulates embryonic urinary bladder development in organ culture
  72. Human Vascular Smooth Muscle Cells Express a Urate Transporter
  73. Loss of nitric oxide and endothelial-derived hyperpolarizing factor-mediated responses in aging
  74. IL-10 Suppresses Chemokines, Inflammation, and Fibrosis in a Model of Chronic Renal Disease
  75. How Does Angiotensin II Cause Renal Injury?
  76. Angiopoietin correlates with glomerular capillary loss in anti-glomerular basement membrane glomerulonephritis